4 Marijuana Stocks Starting Strong on Monday (2/11/19)

CORAL GABLES, FL / ACCESSWIRE / February 11, 2019 / Though the marijuana stock market has only existed for a short period of time, it has managed to garner significant attention as companies in the space have worked to create new, innovative products for the cannabis consumer. We've seen, in recent months, an increase in supportive legislation put forth by politicians across the aisle, in favor of legalizing marijuana. As a result of this constant stream of legislation, investors looking to the cannabis sector are growing more excited. These investors are hungry for companies looking for new and innovative ways to incorporate medicinal/recreational cannabis into the lives of consumers. If the cannabis sector continues to earn more public approval, companies in the space may see investors paying closer attention in the near future. Premier Health Group (OTC:PHGRF) (CSE:PHGI), Cronos Group Inc (NASDAQ: CRON, TSX: CRON), Aphria Inc (APHA), and Tilray Inc (TLRY) represent four pot stocks looking to kick off a strong week.

Premier Health Group (OTC:PHGRF) (CSE:PHGI) is a company focused on developing innovative approaches that combine human skill-based expertise with state-of-the-art technologies used throughout the healthcare industry to create the best-possible care solutions for their growing patient network.

Premier Health Group (OTC:PHGRF) (CSE:PHGI) announced towards the end of last week that the Company is now formally entering the cannabis clinic space. Premier's recent acquisition of Cloud Practice Inc has provided an underlying platform to help empower and streamline patient-doctor interaction. Whereas other clinics typically struggle with the labor-intensive process of onboarding patients, this will be done automatically with Premier's smart EMR.

The healthcare professional need only identify patients who could benefit from medical cannabis, and Premier Health Group (OTC:PHGRF) (CSE:PHGI)'s integrated technology will assess the patient's data, and through the use of analytics, output a comprehensive recommendation along with links to corresponding research relevant to the diagnosis.

Dr. Essam Hamza, CEO of Premier Health Group (OTC:PHGRF) (CSE:PHGI), commented, "We are currently working on a partnership model to hard code the decision-making process into the Electronic Medical Records (EMR). There has been a critical gap between the patient's need for medical cannabis and the doctor's knowledge and comfort level in prescribing it. At Premier we understand the frustration felt from both the patient and the doctor and are integrating what we think is a revolutionary process. This new tool will allow us to provide a much-needed service to the 287 clinics and almost 3 million patients in our ecosystem."

For More Information On Premier Health Group, Click Here

Cronos Group Inc (CRON) has enjoyed impressive gains as a result of the Company's announcement in early December 2018 that it had entered into a subscription agreement with Altria Group Inc, pursuant to which Altria has agreed to make n approximately C$2.4 billion equity investment in Cronos Group on a private placement basis in exchange for common shares in the spatial of the Company.

Later this month, the Company will be holding a special meeting of holders of common shares of the Company, at which time Shareholders will be asked to approve both the investment and other matters ancillary to the investment.

For More Information on Cronos Group Inc, Click Here

Aphria Inc (APHA) made headlines last week that the Company, and its Board of Directors, decided to reject the hostile bid offer from Green Growth Brands Inc, which would see the latter acquire all outstanding shares of Aphria including any common shares that may become issued and outstanding after January 22, 2019, but prior to the expiry of the hostile bid upon the exercise, conversion or exchange of options, warrants, debentures or other securities of the Company exercisable or convertible into Common Shares, other than Common Shares owned by GGB or its affiliates, in exchange for 1.5714 shares of GGB.

Per the discussion held by the Company's board, the deal would have negative repercussions, including delisting from the TSX and NYSE and a potential reduction in interest from strategic partners, that could destroy value for Aphria shareholders, with minimal offsetting operational, financial or strategic benefits.